Management of Advanced and Metastatic Prostate Cancer, An Issue of Urologic Clinics of North America
- 1st Edition, Volume 53-2 - April 16, 2026
- Latest edition
- Editor: Isaac Yi Kim
- Language: English
In this issue of Urologic Clinics of North America, guest editor Dr. Isaac Yi Kim brings his considerable expertise to the topic of Management of Advanced and Metastatic Prostate… Read more
Purchase options
Description
Description
In this issue of Urologic Clinics of North America, guest editor Dr. Isaac Yi Kim brings his considerable expertise to the topic of Management of Advanced and Metastatic Prostate Cancer. Although prostate cancer is generally considered curable, advanced and metastatic prostate cancer remain a challenge for urologists and oncologists. In this issue, top experts discuss pelvic lymph node dissection; radiotherapy for high-risk prostate cancer; managing clinical N1 prostate cancer; managing biochemical recurrence after definitive local therapy; and more.
Key features
Key features
- Contains 14 relevant, practice-oriented topics, including imaging-based diagnostics and therapeutics in advanced prostate cancer; surgical management of high-risk prostate cancer; neoadjuvant and adjuvant therapies for high-risk prostate cancer; recent advances in understanding the biology of castration-resistant prostate cancer; treatments on the horizon for men with advanced prostate cancer; and more
- Provides in-depth clinical reviews on management of advanced and metastatic prostate cancer, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Urology
Table of contents
Table of contents
High Risk Prostate Cancer: What is it?
Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches
Surgical Management of High-Risk Prostate Cancer
Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer: Should It be Done?
Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma
Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer
Managing Clinical N1 Prostate Cancer
Managing Prostate Cancer Biochemical Recurrence after Definitive Local Therapy
Systemic Treatments in Men with De Novo Metastatic Prostate Cancer
Cytoreductive Radical Prostatectomy in Men with De Novo Metastatic Prostate Cancer
Radiotherapy in Men with De Novo Metastatic Prostate Cancer
Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer
Systemic Treatments of Castration-Resistant Prostate Cancer
Treatments on the Horizon for Men with Advanced Prostate Cancer
Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches
Surgical Management of High-Risk Prostate Cancer
Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer: Should It be Done?
Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma
Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer
Managing Clinical N1 Prostate Cancer
Managing Prostate Cancer Biochemical Recurrence after Definitive Local Therapy
Systemic Treatments in Men with De Novo Metastatic Prostate Cancer
Cytoreductive Radical Prostatectomy in Men with De Novo Metastatic Prostate Cancer
Radiotherapy in Men with De Novo Metastatic Prostate Cancer
Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer
Systemic Treatments of Castration-Resistant Prostate Cancer
Treatments on the Horizon for Men with Advanced Prostate Cancer
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 53-2
- Published: April 16, 2026
- Language: English
About the editor
About the editor
IK
Isaac Yi Kim
Affiliations and expertise
Chief, Chair, Professor, Department of Urology, Yale University School of Medicine, New Haven, CT, USA